These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10099132)

  • 1. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens.
    Fink BE; Mortensen DS; Stauffer SR; Aron ZD; Katzenellenbogen JA
    Chem Biol; 1999 Apr; 6(4):205-19. PubMed ID: 10099132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of agonism and antagonism in the oestrogen receptor.
    Brzozowski AM; Pike AC; Dauter Z; Hubbard RE; Bonn T; Engström O; Ohman L; Greene GL; Gustafsson JA; Carlquist M
    Nature; 1997 Oct; 389(6652):753-8. PubMed ID: 9338790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core.
    Compton DR; Carlson KE; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5681-4. PubMed ID: 15482947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.
    Singh US; Shankar R; Yadav GP; Kharkwal G; Dwivedi A; Keshri G; Singh MM; Moulik PR; Hajela K
    Eur J Med Chem; 2008 Oct; 43(10):2149-58. PubMed ID: 18155810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
    Guo ZR; Yi X; Xu ZB
    Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
    Stauffer SR; Huang YR; Aron ZD; Coletta CJ; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):151-61. PubMed ID: 11197335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.
    Srivastava BK; Soni R; Joharapurkar A; Sairam KV; Patel JZ; Goswami A; Shedage SA; Kar SS; Salunke RP; Gugale SB; Dhawas A; Kadam P; Mishra B; Sadhwani N; Unadkat VB; Mitra P; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2008 Feb; 18(3):963-8. PubMed ID: 18207393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen pyrazoles: defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor.
    Stauffer SR; Huang Y; Coletta CJ; Tedesco R; Katzenellenbogen JA
    Bioorg Med Chem; 2001 Jan; 9(1):141-50. PubMed ID: 11197334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 3D models of octopus estrogen receptor with estradiol: evidence for steric clashes that prevent estrogen binding.
    Baker ME; Chandsawangbhuwana C
    Biochem Biophys Res Commun; 2007 Sep; 361(3):782-8. PubMed ID: 17678875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural aspects of agonism and antagonism in the oestrogen receptor.
    Pike AC; Brzozowski AM; Walton J; Hubbard RE; Bonn T; Gustafsson JA; Carlquist M
    Biochem Soc Trans; 2000; 28(4):396-400. PubMed ID: 10961927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
    Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
    J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
    Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
    J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indazole estrogens: highly selective ligands for the estrogen receptor beta.
    De Angelis M; Stossi F; Carlson KA; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2005 Feb; 48(4):1132-44. PubMed ID: 15715479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antioxidant activity of oxazolyl/thiazolylsulfonylmethyl pyrazoles and isoxazoles.
    Padmaja A; Rajasekhar C; Muralikrishna A; Padmavathi V
    Eur J Med Chem; 2011 Oct; 46(10):5034-8. PubMed ID: 21864949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment.
    Zhao C; Toresson G; Xu L; Koehler KF; Gustafsson JA; Dahlman-Wright K
    Biochemistry; 2005 Jun; 44(22):7936-44. PubMed ID: 15924412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of tissue selectivity in estrogen receptor modulators.
    Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.